Skip to content
Peptigraph home

hCG for Men: Studies and Label Warnings

Studies of hCG that enrolled only men, what they measured, and what is still unproven.

Medical review pendingGonadotropinUpdated
Strongest evidence
Human RCT
Studies enrolling only men
13
in our evidence file (PubMed search, 11 Oct 2026)
FDA status
FDA approved (prescription only)

Studies that enrolled only men

Each row is a study whose participants were described as men only. Results from one sex are not evidence for the other. Studies of animals and cells are not included.

hCG studies that enrolled only men
StudyDesignPopulationDoseFirst outcome
Clinical endocrinology 2024, PMID 38446525Human RCTHealthy volunteers (8 and 7 in two cross-over studies) and 52 gonadotrophin-deficient men on multi-dose hCG1500 IU or 5000 IU urinary; 62.5 or 250 microg recombinantTestosterone response: Urinary and recombinant hCG gave similar testosterone peaks and timing, apart from a mildly lower early (<48 h) response with urinary.
Endocrine practice 2024, PMID 39025301Human RCTMen with congenital hypogonadotropic hypogonadism (open-label pilot)low-dose hCG 500 U vs 2000 U three times per week, plus FSH 150 USpermatogenesis: 23 of 30 subjects achieved spermatogenesis, median time 12 months.
Medicine 2019, PMID 31374027Human RCTIdiopathic/isolated hypogonadotropic hypogonadism, GnRH pulse vs hCG/hMGNot statedSperm production with hCG/hMG: Sperm produced in 26/103 (25.24%) on hCG/hMG versus 62/117 (52.99%) on GnRH pulse therapy.
BJU international 2018, PMID 29772111Human RCTMen with hypogonadism wishing to preserve fertility5000 IU hCG twice weekly (n = 94) vs clomiphene 50 mg (n = 95) vs both (n = 94)Testosterone: Testosterone rose in all groups to a final mean of 5.17 nmol/L (223% increase) with no difference between hCG, clomiphene or both.
The Journal of clinical endocrinology and metabolism 2015, PMID 25825944Human RCTChinese men with idiopathic hypogonadotropic hypogonadismhCG 2000 U twice weekly with uFSH 75 U three times weekly (continual or sequential)Sperm concentration >= 1.0 x 10(6)/mL: 51.5% (17/33) continual and 55.9% (19/34) sequential FSH/hCG reached sperm concentration of at least 1.0 x 10(6)/mL.
Clinical endocrinology 2009, PMID 19170708Human RCTHealthy men aged 18-45 (anti-doping study)250 or 750 microg recombinant hCG, single doseSerum testosterone after a single dose: Both recombinant hCG doses raised serum and urine testosterone and suppressed LH in healthy men.
The Journal of clinical endocrinology and metabolism 2002, PMID 12107212Human RCTMen over 60 with partial age-related androgen deficiency (testosterone <= 15 nmol/liter, twice)5000 IU (250 microg) recombinant hCGLean body mass and fat mass: Lean body mass rose by about 2 kg (P < 0.001), body weight about 1 kg and fat mass fell about 1 kg (P < 0.05).
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 2016, PMID 26485362Human uncontrolled trialMen with idiopathic hypogonadotropic hypogonadism, before and 6 months after gonadotropin replacementNot statedBody composition: hCG treatment lowered insulin resistance, triglycerides, body fat ratio and waist-to-hip ratio and raised fat free mass in IHH.
Andrology 2026, PMID 41987691Meta-analysisMen with hypogonadotropic hypogonadism and azoospermia; 50 studiesNot statedSpermatogenesis and pregnancy: Gonadotropin therapy induced spermatogenesis in 74% (mean 11.8 months) and pregnancy in 52% of couples with a child wish.
European journal of endocrinology 2024, PMID 38128110Meta-analysisMales with hypogonadotropic hypogonadism, pubertal induction (103 studies)Not statedSpermatogenesis hCG alone vs hCG + FSH: Spermatogenesis 86% with hCG + FSH versus 40% with hCG alone.
Current pharmaceutical design 2021, PMID 32445446ReviewMen with hypogonadotropic hypogonadism treated with gonadotropinsNot statedNot stated
Andrology 2014, PMID 25271205Meta-analysisMen with hypogonadotropic hypogonadism and azoospermia; 44 gonadotropin studiesNot statedSpermatogenesis success rate: Gonadotropin therapy achieved spermatogenesis in 75% (69-81) of men with HH.
Fertility and sterility 2014, PMID 24636400ReviewHypogonadal men with a history of nonprescribed anabolic-androgenic steroid useNot statedManagement of steroid-induced hypogonadism: The review lists hCG among management strategies for anabolic steroid-associated hypogonadism; no quality trials met inclusion.

Peptides studied in men, compared

How strong is it?

Strongest evidence:Human RCT evidence, 4 of 4

A human randomized trial outweighs any number of animal studies. Animal and cell results show a mechanism worth testing, not that it works in people.

Men's health context

MedlinePlus counts prostate cancer and low testosterone among conditions that only affect men.[21]

Trials that enrolled only men

Men with hypogonadism who wished to preserve fertility were randomised to clomiphene, hCG twice weekly, or both; all three treatments were reported as equally effective in restoring testosterone.[4]

In older men given recombinant hCG or placebo by self-injection, testis volume fell by about 5 ml on hCG.[7]

A fertility trial in men with idiopathic hypogonadotropic hypogonadism found sequential urinary FSH/hCG not inferior to the continual regimen.[5]

The authors of a pharmacology study in gonadotrophin-deficient men proposed 62.5 µg as the recombinant hCG pen starting dose for that setting; this is a study conclusion, not a dosing recommendation.[1]

What the labels say for men

The labels list prepubertal cryptorchidism not due to anatomic obstruction as an indication.[22]

Novarel's contraindications include prostatic carcinoma or other androgen-dependent neoplasm.[22]

In men, high doses can cause water and sodium retention, which the Pregnyl label ties to excessive androgen production.[23]

Anabolic steroid users and sport

A review of anabolic steroid-induced hypogonadism lists hCG among management options but found no quality studies for a meta-analysis.[13]

Other peptides people research for men

All peptides for men, compared

Common questions

Has hCG been studied in men?

13 studies we summarise enrolled only men. Results from one sex are not evidence for the other.

Is hCG approved for men?

hCG is FDA approved (prescription only). The label sets who it is approved for; use outside it is off-label.

What does hCG do for men?

The label ties it to male indications: prepubertal cryptorchidism and selected hypogonadotropic hypogonadism.[22]

Does hCG shut down the testes?

A trial of older men on recombinant hCG reported significantly decreased testis volume, by about 5 ml.[7]

More on hCG

Sources

  1. 1Single and multi-dose pharmacology of recombinant and urinary human chorionic gonadotrophin in men.Clinical endocrinology · 2024PMID 38446525Accessed 2 Oct 2026
  2. 2Effect of Combined Low Dose Human Gonadotropic Hormone, Follicle Stimulating Hormone, and Testosterone Therapy (LFT Regimen) Versus Conventional High Dose Human Gonadotropic Hormone and Follicle Stimulating Hormone on Spermatogenesis and Biomarkers in Men With Hypogonadotropic Hypogonadism.Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2024PMID 39025301Accessed 2 Oct 2026
  3. 3Optimal treatment for spermatogenesis in male patients with hypogonadotropic hypogonadism.Medicine · 2019PMID 31374027Accessed 2 Oct 2026
  4. 4Clomiphene citrate and human chorionic gonadotropin are both effective in restoring testosterone in hypogonadism: a short-course randomized study.BJU international · 2018PMID 29772111Accessed 2 Oct 2026
  5. 5Sequential Versus Continual Purified Urinary FSH/hCG in Men With Idiopathic Hypogonadotropic Hypogonadism.The Journal of clinical endocrinology and metabolism · 2015PMID 25825944Accessed 2 Oct 2026
  6. 6Effects of recombinant human LH and hCG on serum and urine LH and androgens in men.Clinical endocrinology · 2009PMID 19170708Accessed 2 Oct 2026
  7. 7A double-blind, placebo-controlled, randomized clinical trial of recombinant human chorionic gonadotropin on muscle strength and physical function and activity in older men with partial age-related androgen deficiency.The Journal of clinical endocrinology and metabolism · 2002PMID 12107212Accessed 2 Oct 2026
  8. 8The Effects of Gonadotropin Replacement Therapy on Metabolic Parameters and Body Composition in Men with Idiopathic Hypogonadotropic Hypogonadism.Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme · 2016PMID 26485362Accessed 2 Oct 2026
  9. 9Boosting Male Fertility: The Impact of Gonadotropin Therapy on Hypogonadotropic Hypogonadism-A Systematic Review and Meta-Analysis.Andrology · 2026PMID 41987691Accessed 2 Oct 2026
  10. 10Gonadotropins for pubertal induction in males with hypogonadotropic hypogonadism: systematic review and meta-analysis.European journal of endocrinology · 2024PMID 38128110Accessed 2 Oct 2026
  11. 11Gonadotropin Treatment for the Male Hypogonadotropic Hypogonadism.Current pharmaceutical design · 2021PMID 32445446Accessed 11 Oct 2026
  12. 12Factors affecting spermatogenesis upon gonadotropin-replacement therapy: a meta-analytic study.Andrology · 2014PMID 25271205Accessed 2 Oct 2026
  13. 13Anabolic steroid-induced hypogonadism: diagnosis and treatment.Fertility and sterility · 2014PMID 24636400Accessed 2 Oct 2026
  14. 14PubMed search: ("human chorionic gonadotropin"[tiab] OR hCG[tiab]) AND (hypogonadism[tiab] OR "male infertility"[tiab] OR hypogonadotropic[tiab] OR testosterone[tiab]) AND (randomized controlled trial[pt] OR meta-analysis[pt]) (97 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  15. 15PubMed search: ("human chorionic gonadotropin"[tiab] OR hCG[tiab]) AND (obesity[tiab] OR "weight loss"[tiab]) AND (randomized controlled trial[pt] OR meta-analysis[pt] OR systematic review[pt]) (11 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  16. 16PubMed search: ("human chorionic gonadotropin"[tiab] OR hCG[tiab]) AND (testosterone replacement[tiab] OR TRT[tiab] OR "anabolic steroid"[tiab] OR bodybuilder*[tiab] OR "lean body mass"[tiab] OR "muscle"[tiab]) AND humans[mh] (260 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  17. 17PubMed search: ("human chorionic gonadotropin"[tiab] OR hCG[tiab]) AND (half-life[tiab] OR pharmacokinetic*[tiab]) AND men[tiab] NOT pregnan*[tiab] (9 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  18. 18PubMed search: ("human chorionic gonadotropin"[tiab] OR hCG[tiab]) AND (hypogonadism[tiab] OR testosterone[tiab] OR cryptorchidism[tiab] OR "male infertility"[tiab]) AND (adverse[tiab] OR "side effect*"[tiab] OR safety[tiab] OR tolerab*[tiab] OR toxicity[tiab] OR "case report"[pt]) AND humans[mh] (130 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 11 Oct 2026
  19. 19PubMed search: ("chorionic gonadotropin"[tiab] OR hCG[tiab]) AND ("weight loss"[tiab] OR obesity[tiab] OR cryptorchidism[tiab]) AND (adverse[tiab] OR "side effect*"[tiab] OR thromboembol*[tiab] OR "case report"[pt] OR death[tiab]) (61 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 11 Oct 2026
  20. 20PubMed search: ("chorionic gonadotropin"[tiab] OR hCG[tiab]) AND (gynecomastia[tiab] OR "injection site"[tiab] OR hypersensitivity[tiab] OR anaphyla*[tiab]) AND (male[tiab] OR men[tiab] OR boys[tiab]) (95 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 11 Oct 2026
  21. 21Official web pageOfficial web page · web page
  22. 22NOVAREL ® (chorionic gonadotropin) for injection, for intramuscular use Initial U.S. Approval: 1974FDA label, DailyMed · current labeldailymed.nlm.nih.govAccessed 2 Oct 2026
  23. 23Pregnyl ® (chorionic gonadotropin) for injectionFDA label, DailyMed · current labeldailymed.nlm.nih.govAccessed 2 Oct 2026

Found an error? Report a correction.